Head and Neck
This is a lecture-based educational format designed to update attendees on the latest evidence-based practice recommendations for head and neck cancer radiation therapy. Scientific updates which inform practice as well as technological advances which are relevant to best outcomes for patients will be addressed. Attendees will be offered opportunities for self-assessment to test their knowledge and will be equipped with guidance and references to address their gaps in knowledge or understanding. The lecturer will also be available to answer questions from attendees to further refine their understanding of the presentation.
The activity is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, nurses and all other health professionals involved in the field of radiation oncology.
Upon completion of this activity, participants should be able to do the following:
- Select appropriate radiation dose and fractionation schedules for early and advanced-stage nasopharynx, oropharynx, larynx, and hypopharynx cancer patients.
- Coordinate surgery timing and chemotherapy if needed into the management of oral cavity, larynx, and hypopharynx cancer patients who will require postoperative radiation therapy.
- Carry out target delineation for intensity modulated radiation therapy planning according to standard international guidelines.
Sue Yom, MD, is employed by the University of California, San Francisco and receives compensation from Bristol-Myers Squibb, Elsevier, EMD Serono, National Institutes of Health, NRG Oncology, Springer, and UpToDate. She holds leadership positions with ASTRO and NRG Oncology.
All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.50 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.50 Certificate of AttendanceThis activity was designated for 1.50 AMA PRA Category 1 Credit™.